Publications

Return

1. •1981-1989
   

Nemerow GR, Cooper NR.  1981  Isolation of Epstein Barr-virus and studies of its neutralization by human IgG and complement. J Immunol. 127:272-278.

Cooper NR, Beebe DP, Nemerow GR.  1982.  Mechanisms of complement-dependent viral neutralization.  In: Dixon FJ, Miesche PA, editors.  Immunopathology: VIIIth international symposium, San Diego, CA 1980.  New York: Academic Press, Inc. p. 529-551.

Nemerow GR, Jensen FC, Cooper NR.  1982.  Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement. J Clin Invest. 70:1081-91.     PMCID: PMC370321

Cooper NR, Nemerow GR, Mayes JT.  1983.  Methods to detect and quantitate complement activation. Springer Semin Immunopathol. 6:195-212. Review.

Cooper NR, Nemerow GR.   1983.  Complement, viruses, and virus-infected cells. Springer Semin Immunopathol. 6:327-347. Review.

Nemerow GR, Cooper NR.  1984.  Early events in the infection of human B lymphocytes by Epstein-Barr virus: the internalization process. Virology. 132:186-98.

Cooper NR, Nemerow GR.  1984.  The role of antibody and complement in the control of viral infections. J Invest Dermatol. 183(1 Suppl):121s-127s. Review

Nemerow GR, Cooper NR.  1984.  Infection of B lymphocytes by a human herpesvirus, Epstein-Barr virus, is blocked by calmodulin antagonists. Proc Natl Acad Sci U S A. 81:4955-4959.     PMCID: PMC391611

Nemerow GR, Cooper NR.  1985.  The role of calmodulin in the infection of human B lymphocytes by Epstein-Barr virus. Trans Assoc Am Physicians. 97:232-241.

Nemerow GR, McNaughton ME, Cooper NR.  1985.  Monoclonal antibody to the Epstein-Barr virus receptor induces human B lymphocyte activation and differentiation. Trans Assoc Am Physicians. 98:290-300.

Cooper NR,  Nemerow GR.  1985.  Complement effector mechanisms in health and disease. J Invest Dermatol. 85(1 Suppl):39s-46s.  Review.

Nemerow GR, Wolfert R, McNaughton ME, Cooper NR.  1985.  Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2). J Virol. 55(2):347-351.      PMCID: PMC254939

Nemerow GR, McNaughton ME, Cooper NR.  1985.  Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes. J Immunol. 135(5):3068-3073.

Nemerow GR, Siaw MF, Cooper NR.  1986.  Purification of the Epstein-Barr virus/C3d complement receptor of human B lymphocytes: antigenic and functional properties of the purified protein. J Virol. 58(2):709-712.  PMCID: PMC252969

Siaw MF, Nemerow GR, Cooper NR.  1986.  Biochemical and antigenic analysis of the Epstein Barr virus/C3d receptor (CR2). J Immunol. 136(11):4146-4151.

Mold C, Cooper NR, Nemerow GR.  1986.  Incorporation of the purified Epstein Barr virus/C3d receptor (CR2) into liposomes and demonstration of its dual ligand binding functions. J Immunol. 136(11):4140-4145.

Nemerow GR, Siaw, MFE, Cooper NR.  1986.  Biological significance of the Epstein-Barr virus receptor on B lymphocytes.  In: Crowell RL,  Lonberg-Holm K, editors. Virus Attachment and entry into cells. Proceedings of an ASM conference held in Philadelphia, Pennsylavia, 10-13 April 1985.  Washington, D.C.: American Society of Microbiology Press.   p. 160-167.

Cooper NR, Nemerow GR.  1986.  Complement-dependent mechanisms of virus neutralization.  In:   Ross GD, editor.  Immunobiology of the complement system.   Orlando: Academic Press, Inc. p. 139-162.

Nemerow GR, Cooper NR.  1987.  Virus receptors on lymphoid cells.  In: DiSabato  G, Langone JJ, vanVunakis H, editors. Methods in enzymology.  Immunochemical techniques Part K: in vitro models of B and T cell functions and lymphoid cell receptors.   Orlando: Academic Press, Inc. 150:548-558.

Nemerow GR, Mold C, Schwend VK, Tollefson V, Cooper NR.  1987.  Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d. J Virol. 61(5):1416-1420.     PMCID: PMC254117

Moore MD, Cooper NR, Tack BF, Nemerow GR.  1987.  Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes. Proc Natl Acad Sci U S A. 84:9194-9198.

PMCID: PMC299719

Cooper NR, Moore MD, Nemerow GR. 1988.  Immunobiology of CR2, the B lymphocyte receptor for Epstein-Barr virus and the C3d complement fragment.  Ann Rev Immunol. 6:85-113. Review.

Mold C, Nemerow GR, Bradt BM, Cooper NR.  1988.  CR2 is a complement activator and the covalent binding site for C3 during alternative pathway activation by Raji cells.  J Immunol.  140(6):1923-1929.

Mold C, Bradt BM, Nemerow GR, Cooper NR.  1988.  Activation of the alternative complement pathway by EBV and the viral envelope glycoprotein, gp350. J Immunol. 140(11):3867-3874.

Mold C, Bradt BM,  Nemerow GR, Cooper NR.  1988.  Epstein-Barr virus regulates activation and processing of the third component of complement. J Exp Med. 168(3):949-969.   PMCID: PMC2189017

Cooper NR,  Nemerow GR.  1989.  Complement and infectious agents: a tale of disguise and deception.  Complement Inflamm. 6:249-258. Review.

Nemerow GR, Houghten RA, Moore MD, Cooper NR.  1989.  Identification of an epitope in the major envelope protein of Epstein-Barr virus that mediates viral binding to the B lymphocyte EBV receptor (CR2). Cell. 56:369-377.

Moore MD, DiScipio RG, Cooper NR,  Nemerow GR.  1989.  Hydrodynamic, electron microscopic, and ligand-binding analysis of the Epstein-Barr virus/C3dg receptor (CR2). J Biol Chem. 264(34):20576-20582.

Return